Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Agilent, Picometrics In Mass Spec Pact | Contract Pharma
Breaking News, Collaborations & Alliances

Agilent, Picometrics In Mass Spec Pact

Will provide combined solutions for CE-LIF detection

Agilent Technologies, Inc. and Picometrics Technologies have signed a co-marketing agreement to provide combined solutions for capillary electrophoresis (CE), laser induced fluorescence (LIF) detection, and mass spectrometry, to biopharmaceutical customers. The collection of tools will provide an online CE-LIF-MS solution suitable for R&D of complex large-molecule compounds.
 
“We are very pleased to extend a long-standing and fruitful partnership with Agilent and consolidate our development strategy,” said Jean Charles Garcia, president of Picometrics. “This unique technological platform using our new-generation LIF detection will significantly increase efficiency for biotherapeutic characterization in research, development and quality control.”
 
“We are excited to collaborate with Picometrics and provide this unique product offering to the biopharmaceutical industry—particularly those focusing on the research and development of NBEs, or new biological entities,” said Michael Frank, Agilent marketing director, liquid phase separations. “As conventional drug research becomes outmoded in meeting the increasing demands of complex, large-molecule drug development, scientists need highly sophisticated tools like these to advance therapeutic discovery.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters